Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2012 Jul 15;144(3):584–603. doi: 10.1016/j.jtcvs.2012.05.044

TABLE 5.

Causes of Death in 1287 LVAD* Destination Therapy Patients INTERMACS June 2006 – December 2011

Pulsatile Flow Pumps
Early (≤ mon) Later (>1 mon) Total



(n = 13) (n = 53) (n = 66)



Primary cause of death No % No % No %
Cardiac failure
    RV failure 2 15% 4 8% 6 9%
    Arrhythmia/Other 1 8% 6 11% 7 11%
Infection 1 8% 8 15% 9 14%
CNS event 5 38% 7 13% 12 18%
Multiorgan failure 0 0% 3 6% 3 5%
Respiratory failure 2 15% 1 2% 3 5%
Bleeding
  Gastrointestinal 0 0% 0 0% 0 0%
  Surgical 1 8% 0 0% 1 1%
  Other Bleeding 1 8% 2 4% 3 5%
Device failure 0 0% 3 6% 3 5%
Renal failure 0 0% 1 2% 1 1%
Hepatic failure 0 0% 1 2% 1 1%
Malignancy 0 0% 1 2% 1 1%
Arterial embolism 0 0% 0 0% 0 0%
Cardiac tamponade 0 0% 0 0% 0 0%
Withdrawal of support 0 0% 0 0% 0 0%
Other 0 0% 16 30% 16 24%

Total 13 100% 53 100% 66 100%

CNS, central nervous system; INTERMACS, Interagency Registry for Mechanical Circulatory Support; LVAD, left ventricular assist device.

*

includes RVADs implanted at the time of LVAD or subsequent to LVAD implant.